Stocks / NASDAQ / OncoMed Pharmaceuticals, Inc.

OncoMed Pharmaceuticals, Inc.

Our Opinion

OncoMed Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in discovery and development of some of their therapeutics.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“Notably, the effect on inhibiting tumor growth persists upon re-challenging cured animals with re-injection of tumor cells, indicating that we are inducing a long-term immune memory response that we hope will translate into long-term clinical benefit.” Read the following article

Company Description

OncoMed Pharmaceuticals, Inc. is a clinical development-stage biotechnology company. It engages in the provision of discovering and developing protein therapeutics targeting cancer stem cells. The company was founded by Drs. Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. [Source: MarketWatch]

Company Website: